Clinical Trials · NCT01917656
Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 343
- Start date
- Jan 2014
- Locations
- 41 sites, 7 countries
- Primary endpoint
- Change in Fructosamine From Start of Ramadan to End of Ramadan